1. Home
  2. GBIO vs FCCO Comparison

GBIO vs FCCO Comparison

Compare GBIO & FCCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GBIO
  • FCCO
  • Stock Information
  • Founded
  • GBIO 2016
  • FCCO 1994
  • Country
  • GBIO United States
  • FCCO United States
  • Employees
  • GBIO N/A
  • FCCO N/A
  • Industry
  • GBIO Biotechnology: Pharmaceutical Preparations
  • FCCO Major Banks
  • Sector
  • GBIO Health Care
  • FCCO Finance
  • Exchange
  • GBIO Nasdaq
  • FCCO Nasdaq
  • Market Cap
  • GBIO 29.2M
  • FCCO 182.4M
  • IPO Year
  • GBIO 2020
  • FCCO 1998
  • Fundamental
  • Price
  • GBIO $0.39
  • FCCO $24.98
  • Analyst Decision
  • GBIO Strong Buy
  • FCCO Strong Buy
  • Analyst Count
  • GBIO 4
  • FCCO 2
  • Target Price
  • GBIO $7.33
  • FCCO $30.00
  • AVG Volume (30 Days)
  • GBIO 1.1M
  • FCCO 75.7K
  • Earning Date
  • GBIO 08-06-2025
  • FCCO 07-23-2025
  • Dividend Yield
  • GBIO N/A
  • FCCO 2.37%
  • EPS Growth
  • GBIO N/A
  • FCCO 37.48
  • EPS
  • GBIO N/A
  • FCCO 1.98
  • Revenue
  • GBIO $24,556,000.00
  • FCCO $67,933,000.00
  • Revenue This Year
  • GBIO N/A
  • FCCO $18.61
  • Revenue Next Year
  • GBIO N/A
  • FCCO $11.88
  • P/E Ratio
  • GBIO N/A
  • FCCO $12.79
  • Revenue Growth
  • GBIO 146.47
  • FCCO 16.46
  • 52 Week Low
  • GBIO $0.30
  • FCCO $16.40
  • 52 Week High
  • GBIO $3.65
  • FCCO $27.96
  • Technical
  • Relative Strength Index (RSI)
  • GBIO 52.02
  • FCCO 65.01
  • Support Level
  • GBIO $0.32
  • FCCO $25.01
  • Resistance Level
  • GBIO $0.36
  • FCCO $25.95
  • Average True Range (ATR)
  • GBIO 0.03
  • FCCO 0.49
  • MACD
  • GBIO 0.00
  • FCCO 0.18
  • Stochastic Oscillator
  • GBIO 81.00
  • FCCO 79.89

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable highly differentiated therapeutic applications. Its first platform is a potent, highly selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for highly selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

About FCCO First Community Corporation

First Community Corp is a bank holding company. Along with its subsidiaries, it provides various banking products and services for professionals and small and medium-sized businesses, including consumer and commercial banking, mortgage, brokerage and investment, online banking, and insurance services. The company offers checking, savings, money market, individual retirement, and certificates of deposit accounts, and its lending lines include consumer loans, real estate loans, home improvement loans, home loans, flex loans, construction loans, agricultural loans, and others. The company's reportable segments are; Commercial and Retail Banking, which derives maximum revenue; Mortgage Banking; Investment Advisory and Non-Deposit; and Corporate.

Share on Social Networks: